In the context of cancer, aberrant phosphorylation and ubiquitination of ZKSCAN3 can lead to altered transcriptional landscapes that facilitate tumor growth, survival, and metastasis by modulating genes implicated in cell cycle progression, apoptosis inhibition, and metabolic reprogramming. This evidence concerns the gene ZKSCAN3 and cancer.